Lawsonia inermis-loaded poly (L-lactide-co-D, L-lactide) nanofibers for healing acceleration of burn wounds

J Biomater Sci Polym Ed. 2023 Jun;34(8):1019-1035. doi: 10.1080/09205063.2022.2155779. Epub 2022 Dec 14.

Abstract

This study aimed to develop a new bioactive wound dressing based on electrospun poly (L-lactide-co-D, L-lactide) (PLDLLA) nanofibers containing Lawsonia inermis (LI) for burn wounds. The SEM results showed that loading LI increased the average diameter of PLDLLA nanofibers to 528 nm with smooth and beadless morphology. The analysis of LI release from PLDLLA nanofibers and film samples was measured by UV-vis spectrophotometry, and the obtained results revealed that LI molecules could diffuse from the nanofibrous sample with higher rate than film during 48 h. In this regard, the PLDLLA nanofibrous sample as a drug carrier has advantages compared to the film. Moreover, the antibacterial results confirmed the positive influence of LI related to the bacteria which in turn the growth inhibition zones were increased from 6 to 22 mm for P. aeruginosa, and from 3 to 16 mm for S. aureus while the LI concentration was set at 1.4% (w/v). Finally, animal model studies demonstrated that PLDLLA-LI nanofibers accelerated burn wound closure remarkably; thereby decreasing the wound area approximately 90% during the treatment period of 19 days. The histological observations dedicated that the appearance of the epithelial layer was increased dramatically alongside the thickness of around 40% for the wound treated with PLDLLA-LI nanofibrous sample rather than that without LI. Besides the epithelialization, it has been found that the wound covered by PLDLLA-LI wound dressing has condensed collagen fibers with no necrosis.

Keywords: Burn wound; Electrospinning; Lawsonia Inermis; Nanofibers; Poly (lactic acid) copolymer.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Burns* / drug therapy
  • Burns* / pathology
  • Lawsonia Plant*
  • Nanofibers*
  • Staphylococcus aureus

Substances

  • dilactide
  • Anti-Bacterial Agents